TCL Archive FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight December 17, 2010
TCL Archive Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990 January 27, 1989